vs

Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $41.3M, roughly 1.8× Northfield Bancorp, Inc.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -1545.5%, a 1552.9% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 15.0%).

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

NFBK vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.8× larger
VMD
$76.2M
$41.3M
NFBK
Growing faster (revenue YoY)
VMD
VMD
+12.8% gap
VMD
25.5%
12.7%
NFBK
Higher net margin
VMD
VMD
1552.9% more per $
VMD
7.4%
-1545.5%
NFBK
More free cash flow
NFBK
NFBK
$42.8M more FCF
NFBK
$52.5M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
15.0%
NFBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NFBK
NFBK
VMD
VMD
Revenue
$41.3M
$76.2M
Net Profit
$-27.4M
$5.6M
Gross Margin
57.9%
Operating Margin
-1263.3%
11.0%
Net Margin
-1545.5%
7.4%
Revenue YoY
12.7%
25.5%
Net Profit YoY
-343.6%
30.7%
EPS (diluted)
$-0.68
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NFBK
NFBK
VMD
VMD
Q4 25
$41.3M
$76.2M
Q3 25
$39.2M
$71.9M
Q2 25
$38.9M
$63.1M
Q1 25
$34.8M
$59.1M
Q4 24
$36.7M
$60.7M
Q3 24
$31.8M
$58.0M
Q2 24
$31.5M
$55.0M
Q1 24
$31.3M
$50.6M
Net Profit
NFBK
NFBK
VMD
VMD
Q4 25
$-27.4M
$5.6M
Q3 25
$10.8M
$3.5M
Q2 25
$9.6M
$3.2M
Q1 25
$7.9M
$2.6M
Q4 24
$11.3M
$4.3M
Q3 24
$6.5M
$3.9M
Q2 24
$6.0M
$1.5M
Q1 24
$6.2M
$1.6M
Gross Margin
NFBK
NFBK
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
NFBK
NFBK
VMD
VMD
Q4 25
-1263.3%
11.0%
Q3 25
37.7%
7.8%
Q2 25
35.6%
8.1%
Q1 25
31.0%
6.5%
Q4 24
38.0%
10.6%
Q3 24
27.9%
9.7%
Q2 24
29.1%
6.6%
Q1 24
27.2%
4.4%
Net Margin
NFBK
NFBK
VMD
VMD
Q4 25
-1545.5%
7.4%
Q3 25
27.4%
4.9%
Q2 25
24.6%
5.0%
Q1 25
22.6%
4.4%
Q4 24
30.7%
7.1%
Q3 24
20.5%
6.7%
Q2 24
18.9%
2.7%
Q1 24
19.9%
3.2%
EPS (diluted)
NFBK
NFBK
VMD
VMD
Q4 25
$-0.68
$0.14
Q3 25
$0.27
$0.09
Q2 25
$0.24
$0.08
Q1 25
$0.19
$0.06
Q4 24
$0.27
$0.10
Q3 24
$0.16
$0.10
Q2 24
$0.14
$0.04
Q1 24
$0.15
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NFBK
NFBK
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$164.0M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$690.1M
$141.5M
Total Assets
$5.8B
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NFBK
NFBK
VMD
VMD
Q4 25
$164.0M
$13.5M
Q3 25
$131.7M
$11.1M
Q2 25
$97.6M
$20.0M
Q1 25
$101.7M
$10.2M
Q4 24
$167.7M
$17.5M
Q3 24
$232.9M
$11.3M
Q2 24
$153.5M
$8.8M
Q1 24
$238.8M
$7.3M
Total Debt
NFBK
NFBK
VMD
VMD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$666.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NFBK
NFBK
VMD
VMD
Q4 25
$690.1M
$141.5M
Q3 25
$719.6M
$133.6M
Q2 25
$710.3M
$139.7M
Q1 25
$711.1M
$134.8M
Q4 24
$704.7M
$131.4M
Q3 24
$699.6M
$125.0M
Q2 24
$693.0M
$119.4M
Q1 24
$698.4M
$116.3M
Total Assets
NFBK
NFBK
VMD
VMD
Q4 25
$5.8B
$199.2M
Q3 25
$5.7B
$202.4M
Q2 25
$5.7B
$184.6M
Q1 25
$5.7B
$178.1M
Q4 24
$5.7B
$177.1M
Q3 24
$5.7B
$169.5M
Q2 24
$5.7B
$163.9M
Q1 24
$5.9B
$154.9M
Debt / Equity
NFBK
NFBK
VMD
VMD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.95×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NFBK
NFBK
VMD
VMD
Operating Cash FlowLast quarter
$53.7M
$18.4M
Free Cash FlowOCF − Capex
$52.5M
$9.7M
FCF MarginFCF / Revenue
127.1%
12.7%
Capex IntensityCapex / Revenue
2.8%
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$89.2M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NFBK
NFBK
VMD
VMD
Q4 25
$53.7M
$18.4M
Q3 25
$13.9M
$18.4M
Q2 25
$14.1M
$12.3M
Q1 25
$9.4M
$2.9M
Q4 24
$31.1M
$15.0M
Q3 24
$14.0M
$12.7M
Q2 24
$6.9M
$10.2M
Q1 24
$4.2M
$1.2M
Free Cash Flow
NFBK
NFBK
VMD
VMD
Q4 25
$52.5M
$9.7M
Q3 25
$13.6M
$10.7M
Q2 25
$13.9M
$4.1M
Q1 25
$9.2M
$-12.6M
Q4 24
$30.0M
$3.2M
Q3 24
$13.7M
$1.7M
Q2 24
$6.7M
$1.2M
Q1 24
$3.8M
$-4.8M
FCF Margin
NFBK
NFBK
VMD
VMD
Q4 25
127.1%
12.7%
Q3 25
34.6%
14.9%
Q2 25
35.7%
6.5%
Q1 25
26.3%
-21.4%
Q4 24
81.6%
5.2%
Q3 24
43.2%
3.0%
Q2 24
21.1%
2.3%
Q1 24
12.1%
-9.5%
Capex Intensity
NFBK
NFBK
VMD
VMD
Q4 25
2.8%
11.5%
Q3 25
0.8%
10.6%
Q2 25
0.6%
12.9%
Q1 25
0.7%
26.2%
Q4 24
3.1%
19.5%
Q3 24
0.7%
19.0%
Q2 24
0.8%
16.3%
Q1 24
1.4%
11.9%
Cash Conversion
NFBK
NFBK
VMD
VMD
Q4 25
3.27×
Q3 25
1.29×
5.23×
Q2 25
1.48×
3.88×
Q1 25
1.20×
1.09×
Q4 24
2.76×
3.47×
Q3 24
2.14×
3.29×
Q2 24
1.16×
6.94×
Q1 24
0.68×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons